Central Nervous System Neoplasm — Trials

Central Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,063 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 401–450 of 1,652 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07410520	PD-1 Inhibitor Combined With Rituximab, Methotrexate, and Orelabrutinib (PD-1i+RMO) for Newly Diagnosed PCNSL and SCNSL.	recruiting	Phase 2	50	The First Affiliated Hospital with Nanjing Medical UniversityOTHER	1	Feb 13, 2026	clinicaltrials
NCT03529448	TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma(GEINOCANN)	completed	Phase 1 / Phase 2	33	Grupo Español de Investigación en NeurooncologíaOTHER